Antidepressant‐like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus
Open Access
- 15 February 2012
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 166 (6), 1872-1887
- https://doi.org/10.1111/j.1476-5381.2012.01902.x
Abstract
BACKGROUND AND PURPOSE Ginsenoside Rg1 (Rg1) is one of the major bioactive ingredients of Panax ginseng with little toxicity and has been shown to have neuroprotective effects. In this study, we investigated the antidepressant-like effect of Rg1 in models of depression in mice. EXPERIMENTAL APPROACH The effects of Rg1 were assessed in the forced swimming test (FST) and tail suspension test (TST) in mice. Rg1 was also investigated in the chronic mild stress (CMS) mouse model of depression with imipramine as the positive control. Changes in hippocampal neurogenesis and spine density, the brain-derived neurotrophic factor (BDNF) signalling pathway, and serum corticosterone level after chronic stress and Rg1 treatment were then investigated. The tryptophan hydroxylase inhibitor and the tyrosine kinase B inhibitor were also used to explore the antidepressive mechanisms of Rg1. KEY RESULTS Ginsenoside Rg1 exhibited antidepressant-like activity in the FST and TST in mice without affecting locomotor activity. It was also effective in the CMS model of depression. Furthermore, Rg1 up-regulated the BDNF signalling pathway in the hippocampus and down-regulated serum corticosterone level during the CMS procedure. In addition, Rg1 was able to reverse the decrease in dendritic spine density and hippocampal neurogenesis caused by CMS. However, Rg1 had no discernable effect on the monoaminergic system. CONCLUSIONS AND IMPLICATIONS Our results provide the first evidence that Rg1 has antidepressant activity via activation of the BDNF signalling pathway and up-regulation of hippocampal neurogenesis.Keywords
This publication has 86 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 5th editionBritish Journal of Pharmacology, 2011
- Effect of brain‐derived neurotrophic factor haploinsufficiency on stress‐induced remodeling of hippocampal neuronsHippocampus, 2011
- The 5-HT7 receptor as a mediator and modulator of antidepressant-like behaviorBehavioural Brain Research, 2010
- Adult hippocampal neurogenesis is functionally important for stress-induced social avoidanceProceedings of the National Academy of Sciences of the United States of America, 2010
- Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF‐I receptor signalling pathwayBritish Journal of Pharmacology, 2009
- Antidepressant- and Anxiolytic-like Effects of the Phosphodiesterase-4 Inhibitor Rolipram on Behavior Depend on Cyclic AMP Response Element Binding Protein-Mediated Neurogenesis in the HippocampusNeuropsychopharmacology, 2009
- The molecular neurobiology of depressionNature, 2008
- Regionally Specific Regulation of ERK MAP Kinase in a Model of Antidepressant-Sensitive Chronic DepressionBiological Psychiatry, 2008
- Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant EfficacyBiological Psychiatry, 2007
- Chronic mild stress-induced anhedonia: A realistic animal model of depressionNeuroscience & Biobehavioral Reviews, 1992